News
In this issue, Lehmann et al 1 report that cisplatin plus methotrexate (CM) is not inferior to methotrexate, vinblastine, epirubicin, and cisplatin (M-VEC) in the adjuvant treatment of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback